[HTML][HTML] Advances in the treatment of Chagas disease: Promising new drugs, plants and targets
P García-Huertas, N Cardona-Castro - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Chagas disease, caused by Trypanosoma cruzi, is treated with only two drugs;
benznidazole and nifurtimox. These drugs have some disadvantages, including their …
benznidazole and nifurtimox. These drugs have some disadvantages, including their …
A critical review on Chagas disease chemotherapy
JR Coura, SL De Castro - Memórias do Instituto Oswaldo Cruz, 2002 - SciELO Brasil
In this" Critical Review" we made a historical introduction of drugs assayed against Chagas
disease beginning in 1912 with the works of Mayer and Rocha Lima up to the experimental …
disease beginning in 1912 with the works of Mayer and Rocha Lima up to the experimental …
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial
CA Morillo, H Waskin, S Sosa-Estani… - Journal of the American …, 2017 - jacc.org
Background: Benznidazole is recommended for treatment of Chagas infection. Effects of
combination therapy with benznidazole and posaconazole have not been tested in …
combination therapy with benznidazole and posaconazole have not been tested in …
Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches
JA Urbina - Acta tropica, 2010 - Elsevier
A critical review of the development of specific chemotherapeutic approaches for the
management of American Trypanosomiasis or Chagas disease is presented, including …
management of American Trypanosomiasis or Chagas disease is presented, including …
Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms
GI Lepesheva, MR Waterman - … et biophysica acta (BBA)-General subjects, 2007 - Elsevier
The CYP51 family is an intriguing subject for fundamental P450 structure/function studies
and is also an important clinical drug target. This review updates information on the variety …
and is also an important clinical drug target. This review updates information on the variety …
Short-course combination treatment for experimental chronic Chagas disease
S González, RJ Wall, J Thomas, S Braillard… - Science translational …, 2023 - science.org
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects millions of
people in the Americas and across the world, leading to considerable morbidity and …
people in the Americas and across the world, leading to considerable morbidity and …
Review on Experimental Treatment Strategies Against Trypanosoma cruzi
AL Mazzeti, P Capelari-Oliveira, MT Bahia… - Journal of …, 2021 - Taylor & Francis
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Currently, only nitroheterocyclic nifurtimox (NFX) and benznidazole (BNZ) are …
cruzi. Currently, only nitroheterocyclic nifurtimox (NFX) and benznidazole (BNZ) are …
Ergosterol biosynthesis and drug development for Chagas disease
JA Urbina - Memorias do Instituto Oswaldo Cruz, 2009 - SciELO Brasil
This article presents an overview of the currently available drugs nifurtimox (NFX) and
benznidazole (BZN) used against Trypanosoma cruzi, the aetiological agent of Chagas …
benznidazole (BZN) used against Trypanosoma cruzi, the aetiological agent of Chagas …
Translational challenges of animal models in Chagas disease drug development: a review
E Chatelain, N Konar - Drug design, development and therapy, 2015 - Taylor & Francis
Chagas disease, or American trypanosomiasis, caused by Trypanosoma cruzi parasite
infection is endemic in Latin America and presents an increasing clinical challenge due to …
infection is endemic in Latin America and presents an increasing clinical challenge due to …
New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice
The development of treatment protocols with reduced toxicity and equivalent or improved
efficacy for Trypanosoma cruzi infection is a priority. We tested the effectiveness of …
efficacy for Trypanosoma cruzi infection is a priority. We tested the effectiveness of …